[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$fT0fCoQLFgP2zjUU9TZvce0LbkvmFiQVUUyeFeccnSJc":3},{"item":4,"storyV2":100},{"slug":5,"type":6,"track":7,"season":8,"date":9,"featured":10,"teamName":11,"institution":13,"projectTitle":15,"summary":18,"body":20,"tags":24,"aiTags":27,"wetlabTags":30,"awards":33,"logoUrl":36,"materials":37,"gallery":38,"editorial":75,"cover":98},"hecheng-yixia","image","T1","2026","2026-01-01",false,{"zh":12,"en":12},"合成一下",{"zh":14,"en":14},"厦门大学化学化工学院",{"zh":16,"en":17},"CD40L 结合蛋白 —— RFdiffusion 从头设计","CD40L-binding proteins — de novo design with RFdiffusion",{"zh":19,"en":19},"以 CD40L 为靶点，从头设计蛋白结合剂，并用 SPR 测到最高 2.77 nM 的亲和力",{"zh":21,"en":23},[22],"厦门大学「合成一下」使用 RFdiffusion 生成骨架、ProteinMPNN 反译序列，筛出五条候选蛋白并以 SPR 复核亲和力。",[22],{"zh":25,"en":26},[],[],{"zh":28,"en":29},[],[],{"zh":31,"en":32},[],[],{"zh":34,"en":35},[],[],"\u002Fapi\u002Fteam-showcase\u002Fhecheng-yixia\u002Fmedia\u002Fcef01d01d44f3bd93c8ceef31",{},[39,47,54,61,68],{"imageUrl":40,"alt":41,"title":43,"description":45,"position":46},"\u002Fapi\u002Fteam-showcase\u002Fhecheng-yixia\u002Fmedia\u002Fcdfd54024963e82cd28d6654f",{"zh":42,"en":42},"六位成员在实验楼前合影；队伍资料显示团队同时推进蛋白计算设计、表达纯化与结合活性检测。",{"zh":44,"en":44},"合成一下团队",{"zh":42,"en":42},"center center",{"imageUrl":48,"alt":49,"title":51,"description":53,"position":46},"\u002Fapi\u002Fteam-showcase\u002Fhecheng-yixia\u002Fmedia\u002Fc1541d29100a4356457ca166a",{"zh":50,"en":50},"成员围在工作站前查看屏幕内容，讨论计算分析与后续实验之间的衔接。",{"zh":52,"en":52},"围绕分析结果复核方案",{"zh":50,"en":50},{"imageUrl":55,"alt":56,"title":58,"description":60,"position":46},"\u002Fapi\u002Fteam-showcase\u002Fhecheng-yixia\u002Fmedia\u002Fca224dfddd17a4c780a5dca28",{"zh":57,"en":57},"刘畅在实验室内留影；这组人物素材与团队合影共同记录六位成员的项目参与。",{"zh":59,"en":59},"刘畅成员照",{"zh":57,"en":57},{"imageUrl":62,"alt":63,"title":65,"description":67,"position":46},"\u002Fapi\u002Fteam-showcase\u002Fhecheng-yixia\u002Fmedia\u002Fcb569533aa739af218d0c78f3",{"zh":64,"en":64},"团队在实验室工作站前共同查看分析界面，把需要继续验证的内容集中核对。",{"zh":66,"en":66},"计算结果集中核对",{"zh":64,"en":64},{"imageUrl":69,"alt":70,"title":72,"description":74,"position":46},"\u002Fapi\u002Fteam-showcase\u002Fhecheng-yixia\u002Fmedia\u002Fc412c436700ab3fdbfa89d50d",{"zh":71,"en":71},"庄炫伟在实验室内留影；团队资料显示成员分别参与计算设计与实验验证。",{"zh":73,"en":73},"庄炫伟成员照",{"zh":71,"en":71},{"proposition":76,"listEvidence":77},{"zh":19,"en":19},[78,83,88,93],{"value":79,"label":81},{"zh":80,"en":80},"6 人",{"zh":82,"en":82},"成员人数",{"value":84,"label":86},{"zh":85,"en":85},"江发龙",{"zh":87,"en":87},"队长",{"value":89,"label":91},{"zh":90,"en":90},"CD40L",{"zh":92,"en":92},"项目靶点",{"value":94,"label":96},{"zh":95,"en":95},"ELISA + SPR",{"zh":97,"en":97},"实验验证",{"tone":99,"heroImageUrl":40,"heroImagePosition":46},"bio",{"version":101,"publicSlug":5,"identity":102,"proposition":106,"lead":107,"listEvidence":108,"narrativeTendency":121,"hero":122,"presentation":127,"chapters":154},2,{"teamName":103,"projectTitle":104,"institution":105,"track":7},{"zh":12,"en":12},{"zh":16,"en":17},{"zh":14,"en":14},{"zh":19,"en":19},{"zh":22,"en":22},[109,112,115,118],{"value":110,"label":111},{"zh":80,"en":80},{"zh":82,"en":82},{"value":113,"label":114},{"zh":85,"en":85},{"zh":87,"en":87},{"value":116,"label":117},{"zh":90,"en":90},{"zh":92,"en":92},{"value":119,"label":120},{"zh":95,"en":95},{"zh":97,"en":97},"evidence-led",{"role":123,"title":124,"caption":125,"alt":126,"position":46,"imageUrl":40},"TEAM",{"zh":44,"en":44},{"zh":42,"en":42},{"zh":42,"en":42},{"template":128,"variant":129,"logo":130,"openingMedia":137},"documentary-profile","rich",{"role":131,"title":132,"caption":134,"alt":136,"position":46,"imageUrl":36},"LOGO",{"zh":133,"en":133},"智构免疫项目标识",{"zh":135,"en":135},"盾形轮廓内组合 CD40L 结合结构与 DNA 双螺旋，对应从头设计结合蛋白的项目方向。",{"zh":135,"en":135},[138,142,146,150],{"role":123,"title":139,"caption":140,"alt":141,"position":46,"imageUrl":48},{"zh":52,"en":52},{"zh":50,"en":50},{"zh":50,"en":50},{"role":123,"title":143,"caption":144,"alt":145,"position":46,"imageUrl":55},{"zh":59,"en":59},{"zh":57,"en":57},{"zh":57,"en":57},{"role":123,"title":147,"caption":148,"alt":149,"position":46,"imageUrl":62},{"zh":66,"en":66},{"zh":64,"en":64},{"zh":64,"en":64},{"role":123,"title":151,"caption":152,"alt":153,"position":46,"imageUrl":69},{"zh":73,"en":73},{"zh":71,"en":71},{"zh":71,"en":71},[155,166,175,208,234,266,295],{"id":156,"eyebrow":157,"title":159,"theme":161,"type":162,"quote":163,"attribution":165},"team-motto",{"zh":158,"en":158},"队伍口号",{"zh":160,"en":160},"队伍声音","people","quote",{"zh":164,"en":164},"智构免疫",{"zh":12,"en":12},{"id":167,"eyebrow":168,"title":170,"body":172,"theme":174,"type":174},"project-background",{"zh":169,"en":169},"项目背景",{"zh":171,"en":171},"CD40L 靶点与从头蛋白设计",{"zh":173,"en":173},"免疫系统是人体抵御疾病的重要防线，而其中蛋白质之间的相互作用对免疫调控发挥着关键作用。项目目标是设计能够特异性结合 CD40L 的新型蛋白分子。改造已有抗体依赖已知模板，从头设计则需要直接建立新的结合结构。RFdiffusion 等生成模型使无天然模板的候选蛋白骨架设计成为可执行方案。","problem",{"id":176,"eyebrow":177,"title":179,"body":181,"theme":183,"type":184,"facts":185,"image":200},"research-context",{"zh":178,"en":178},"研究路径",{"zh":180,"en":180},"计算生成与结构筛选",{"zh":182,"en":182},"第一步使用 RFdiffusion 生成约两千个初始蛋白骨架，仅确定候选结构。第二步使用 ProteinMPNN 为每个骨架反译 5 条候选序列。该步骤从目标折叠反推可形成相应结构的氨基酸序列。第三步使用 AlphaFold2 与 Rosetta 复核结构合理性和结合界面稳定性。复核同时评估候选序列的折叠一致性与 CD40L 结合界面能量。生成、序列设计与结构复核构成相互校验的从头蛋白设计流程。","source","source-context",[186,190,195],{"label":187,"value":189},{"zh":188,"en":188},"靶点",{"zh":90,"en":90},{"label":191,"value":193},{"zh":192,"en":192},"最优亲和力",{"zh":194,"en":194},"KD 2.77 nM",{"label":196,"value":198},{"zh":197,"en":197},"候选",{"zh":199,"en":199},"JFL1–JFL5",{"role":201,"title":202,"caption":204,"alt":206,"position":46,"imageUrl":207},"DRY_LAB",{"zh":203,"en":203},"蛋白设计计算工作站",{"zh":205,"en":205},"工作站屏幕展示蛋白结构与分析界面，计算端据此检查候选结合蛋白。",{"zh":205,"en":205},"\u002Fapi\u002Fteam-showcase\u002Fhecheng-yixia\u002Fmedia\u002Fc8ac3db973d74fa02d745ba98",{"id":209,"eyebrow":210,"title":212,"theme":214,"type":215,"semantics":216,"steps":217},"project-process",{"zh":211,"en":211},"项目过程",{"zh":213,"en":213},"项目推进与验证路径","process","process-flow","hybrid",[218,227],{"order":219,"phase":220,"title":222,"body":224,"status":226},1,{"zh":221,"en":221},"阶段 1",{"zh":223,"en":223},"候选制备与亲和力验证",{"zh":225,"en":225},"SPR 传感图上并排三条曲线，对应候选 JFL2、JFL4、JFL5，JFL2（31.5 nM）和 JFL5（2.77 nM）达到高亲和力水平，JFL4（144 nM）表现为中等亲和力。作为参照，一般认为 KD \u003C 100 nM 可视为较高亲和力，KD \u003C 10 nM 通常属于超高亲和力。按上述标准，JFL5 的 2.77 nM 属于超高亲和力范围。此外完成了分子动力学模拟，用 RMSD、RMSF、Rg、SASA、氢键等指标评价复合物的构象稳定性。","described",{"order":101,"phase":228,"title":230,"body":232,"status":226},{"zh":229,"en":229},"阶段 2",{"zh":231,"en":231},"计算设计流程贯通",{"zh":233,"en":233},"前期调试围绕 RFdiffusion 参数和 ProteinMPNN 序列选择展开。计算链路包括从生成骨架，到 MPNN 反译序列，再到结构预测与 Rosetta 的层层筛选，最后筛得高潜力候选蛋白。",{"id":235,"eyebrow":236,"title":238,"theme":240,"type":241,"items":242},"project-figure",{"zh":237,"en":237},"项目证据",{"zh":239,"en":239},"项目图表与方法记录","evidence","figures",[243,251,259],{"role":244,"title":245,"caption":247,"alt":249,"position":46,"imageUrl":250},"WET_LAB",{"zh":246,"en":246},"蛋白实验操作",{"zh":248,"en":248},"队员在实验设备前完成样品操作，记录候选蛋白进入表达与检测环节的现场。",{"zh":248,"en":248},"\u002Fapi\u002Fteam-showcase\u002Fhecheng-yixia\u002Fmedia\u002Fc05fddef3cd43b249ee721da8",{"role":252,"title":253,"caption":255,"alt":257,"position":46,"imageUrl":258},"RESULT",{"zh":254,"en":254},"ELISA 初筛结果",{"zh":256,"en":256},"图中给出 BSA 与 CD40L 标准曲线，并比较候选结合蛋白的浓度响应关系与 EC50。",{"zh":256,"en":256},"\u002Fapi\u002Fteam-showcase\u002Fhecheng-yixia\u002Fmedia\u002Fcb7cc4d7d5e8ee91fdf006956",{"role":201,"title":260,"caption":262,"alt":264,"position":46,"imageUrl":265},{"zh":261,"en":261},"候选结构分析",{"zh":263,"en":263},"成员在工作站前查看结构与数据结果，为候选蛋白的后续验证整理依据。",{"zh":263,"en":263},"\u002Fapi\u002Fteam-showcase\u002Fhecheng-yixia\u002Fmedia\u002Fce5b3683092c6b14b2ccbeeb5",{"id":267,"eyebrow":268,"title":270,"theme":161,"type":272,"items":273},"team-gallery",{"zh":269,"en":269},"团队协作",{"zh":271,"en":271},"计算、实验与候选复核记录","gallery",[274,281,288],{"role":252,"title":275,"caption":277,"alt":279,"position":46,"imageUrl":280},{"zh":276,"en":276},"复合物 RMSD 轨迹",{"zh":278,"en":278},"四组轨迹记录候选复合物在 200 ns 分子动力学模拟中的骨架位移变化。",{"zh":278,"en":278},"\u002Fapi\u002Fteam-showcase\u002Fhecheng-yixia\u002Fmedia\u002Fc5dcbea0ba2fdb845c08e741a",{"role":252,"title":282,"caption":284,"alt":286,"position":46,"imageUrl":287},{"zh":283,"en":283},"计算设计筛选流程",{"zh":285,"en":285},"流程从 CD40L 界面定义和 RFdiffusion 骨架生成出发，经序列设计、结构预测与界面分析筛选候选。",{"zh":285,"en":285},"\u002Fapi\u002Fteam-showcase\u002Fhecheng-yixia\u002Fmedia\u002Fc75e01ebb2aedef92093f9fd2",{"role":244,"title":289,"caption":291,"alt":293,"position":46,"imageUrl":294},{"zh":290,"en":290},"样品与设备准备",{"zh":292,"en":292},"队员在实验台前准备样品和仪器，为后续结合活性检测保留实验记录。",{"zh":292,"en":292},"\u002Fapi\u002Fteam-showcase\u002Fhecheng-yixia\u002Fmedia\u002Fcfe68606ec12eeb27199b4c31",{"id":296,"eyebrow":297,"title":299,"theme":301,"type":302,"highlight":303,"full":312},"team-interview",{"zh":298,"en":298},"队伍专访",{"zh":300,"en":300},"听 合成一下 讲述项目路径","media","interview",{"version":304,"title":305,"description":307,"durationSeconds":309,"videoUrl":310,"posterUrl":311},"highlight",{"zh":306,"en":306},"项目精华",{"zh":308,"en":308},"项目核心内容与队伍表达的精华剪辑。",194.533333,"\u002Fapi\u002Fteam-showcase\u002Fhecheng-yixia\u002Fmedia\u002Fcfd72a9df8c1678b3925d164f","\u002Fapi\u002Fteam-showcase\u002Fhecheng-yixia\u002Fmedia\u002Fcb47fd86b3a15c4cc07f8f930",{"version":313,"title":314,"description":316,"durationSeconds":318,"videoUrl":319,"posterUrl":311},"full",{"zh":315,"en":315},"完整访谈",{"zh":317,"en":317},"按采访问题完整收录的队伍访谈。",284.5,"\u002Fapi\u002Fteam-showcase\u002Fhecheng-yixia\u002Fmedia\u002Fc0402c0160956e6bb39dafdeb"]